Related Experiment Video
Updated: Jun 29, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
International Comparison of Qualification Process for Medical Product Development Tools.
Daichi Uchijima1, Shingo Kano2
1Bio-Innovation Policy Unit, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Bioscience Bldg B1-17, 5-1-5, Kashiwanoha, Kashiwa City, Chiba, 8562, Japan. uchijima@bioip-lab.org.
Guidance of Guidances (GoG) policies streamline medical product evaluation tool qualification by defining processes and clarifying sponsor involvement. Non-GoG policies support R&D but lack defined qualification pathways, potentially hindering progress.
Area of Science:
- Medical product development
- Regulatory science
- Tool qualification
Background:
- Advancements in medical product science necessitate updated evaluation tools.
- Regulatory bodies in the US, Europe, and Japan are qualifying these tools.
- Different policy approaches exist for tool guidance: Guidance of Guidances (GoG) in the US/EU vs. non-GoG in Japan.
Purpose of the Study:
- To compare the effectiveness of GoG and non-GoG policies in medical product evaluation tool qualification.
- To analyze the lifecycle of development tools, including pre- and post-qualification stages.
Main Methods:
- An analytical framework for the tool development lifecycle was constructed.
- Japanese cases (non-GoG) were compared with Western cases (GoG) as controls.
- The progress of tool qualification and the composition of deliverables were analyzed.
Main Results:
- GoG policies, with defined processes and clear sponsor involvement, facilitate smoother tool qualification.
- GoG policies tend to result in a consistent composition of deliverables.
- Non-GoG policies, while supporting R&D, lack defined tool guidance processes.
Conclusions:
- Defined processes and clear involvement methods under GoG policies enhance tool qualification efficiency.
- GoG policies contribute to standardized deliverables.
- A potential challenge with GoG-only policies is the integration of upstream R&D support tools.
More Related Videos
06:33Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement
Published on: July 29, 2013
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Related Concept Videos
Preclinical Development: Overview
Clinical Trials: Overview
Bioequivalence: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...